Netherlands - English - HMA (Heads of Medicines Agencies)

le vet b.v - medetomidine hydrochloride 1 mg/ml - solution for injection - cats, dogs - medetomidine

Portugal - English - HMA (Heads of Medicines Agencies)

le vet b.v - medetomidine hydrochloride 1 mg/ml - solution for injection - cats, dogs - medetomidine

United Kingdom - English - HMA (Heads of Medicines Agencies)

le vet b.v - medetomidine hydrochloride 1 mg/ml - solution for injection - cats, dogs - medetomidine

Australia - English - Department of Health (Therapeutic Goods Administration)

hospira australia pty ltd - vincristine sulfate, quantity: 1 mg/ml - injection - excipient ingredients: mannitol; water for injections; sulfuric acid; sodium hydroxide - vincristine sulfate is indicated in the treatment of acute leukemia. it has also been used in combination with other antineoplastic drugs in hodgkin's disease, soft-tissue sarcoma, bony-tissue sarcoma, sarcomas of specialized structures, breast cancer, small cell cancer of the lung, cancer of uterine cervix, malignant melanoma, colorectal cancer, non-hodgkin's lymphoma, and wilm's tumor.

New Zealand - English - Medsafe (Medicines Safety Authority)

astrazeneca limited - metoprolol tartrate 1 mg/ml;   - solution for injection - 1 mg/ml - active: metoprolol tartrate 1 mg/ml   excipient: sodium chloride water for injection - betaloc iv is indicated for the following indications: · cardiac arrhythmias, especially supraventricular tachycardia, reduction of ventricular rate in atrial fibrillation and ventricular extrasystoles. · suspected or definite myocardial infarction.

New Zealand - English - Medsafe (Medicines Safety Authority)

max health limited - glycopyrronium bromide 0.2 mg/ml - solution for injection - 0.2 mg/ml - active: glycopyrronium bromide 0.2 mg/ml excipient: hydrochloric acid sodium chloride water for injection - glycopyrrolate is indicated for use as a preoperative antimuscarinic to reduce salivary, tracheobronchial and pharyngeal secretions: to reduce the volume and free acidity of gastric secretions and to block cardiac vagal inhibitory reflexes during induction of anaesthesia and intubation when indicated. glycopyrronium bromide 200 micrograms per ml solution for injection may be used intraoperatively to counteract drug-induced or vagal traction reflexes with the associated arrhythmias. glycopyrrolate protects against the peripheral muscarinic effects (e.g. bradycardia and excessive secretions) of cholinergic agents such as neostigmine and pyridostigmine given to reverse the neuromuscular blockade due to non-depolarising muscle relaxants. for use in adults as adjunctive therapy for the treatment of peptic ulcer when rapid anticholinergic effect is desired or when oral medication is not tolerated.

New Zealand - English - Medsafe (Medicines Safety Authority)

baxter healthcare ltd - midazolam 1 mg/ml - solution for injection - 1 mg/ml - active: midazolam 1 mg/ml excipient: hydrochloric acid hydrochloric acid (ph adjuster) sodium chloride sodium hydroxide water for injection - premedication before induction of anaesthesia (i.m. or, especially in children, rectal, intranasal or oral administration).

United States - English - NLM (National Library of Medicine)

hikma pharmaceuticals usa inc. - atropine sulfate (unii: 03j5ze7ka5) (atropine - unii:7c0697dr9i) - atropine sulfate 0.4 mg in 1 ml - atropine sulfate is given parenterally as a preanesthetic medication to decrease salivation and bronchial secretions. it is useful in pylorospasm and other spastic conditions of the gastrointestinal tract. for ureteral and biliary colic, atropine sulfate given with morphine may be indicated. atropine sulfate is indicated for relaxation of the upper gastrointestinal tract and colon during hypotonic radiography. atropine is used as an antidote for pilocarpine, physostigmine, isoflurophate, choline esters, certain species of aminata and in poisoning by the organic phosphate cholinesterase inhibitors found in certain insecticides and by chemical warfare “nerve gases”. large doses relieve the muscarine-like symptoms and some of the central nervous system manifestations. conditions at which inhibition of postganglionic cholinergic nerves are undesirable, such as glaucoma and tachycardia. also contraindicated in asthma, because the parenteral dose which might relieve asthma would have an excessive drying effect upo

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

hameln pharma ltd - atropine sulfate - solution for injection - 600microgram/1ml

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

advanz pharma - atropine sulfate - solution for injection - 600microgram/1ml